NCT02506348

Brief Summary

In this study we test Diclofenac and Nepafenac and compared patients experience and comfort following administration of these ophthalmic drops.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2015

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

July 2, 2015

Completed
21 days until next milestone

First Posted

Study publicly available on registry

July 23, 2015

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2016

Completed
Last Updated

July 24, 2015

Status Verified

July 1, 2015

Enrollment Period

6 months

First QC Date

July 2, 2015

Last Update Submit

July 22, 2015

Conditions

Post Surgical ManagementPain ManagementInflamation Management

Outcome Measures

Primary Outcomes (1)

  • patient's comfort

    change in patient's comfort between both eyes at 1 min post administration

    1 min post administration

Secondary Outcomes (1)

  • patient's comfort

    5 min post administration

Study Arms (1)

Diclofenac+Nepafenac

EXPERIMENTAL

one drop Diclofenac in one eye one drop Nepafenac in other eye

Drug: DiclofenacDrug: Nepafenac

Interventions

DiclofenacDRUG
Diclofenac+Nepafenac
NepafenacDRUG
Diclofenac+Nepafenac

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patient facing cataract surgery

You may not qualify if:

  • under 18
  • cognitive decline

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The E.Wolfson Medical Center

Holon, 58100, Israel

RECRUITING

MeSH Terms

Conditions

Agnosia

Interventions

Diclofenacnepafenac

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

PhenylacetatesAcids, CarbocyclicCarboxylic AcidsOrganic Chemicals

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
SINGLE
Who Masked
PARTICIPANT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.Asaf Achiron

Study Record Dates

First Submitted

July 2, 2015

First Posted

July 23, 2015

Study Start

July 1, 2015

Primary Completion

January 1, 2016

Last Updated

July 24, 2015

Record last verified: 2015-07

Locations

IL(1)